Clinical Trials Logo

Clinical Trial Summary

The objectives of this study are to determine if the left ventricle outflow tract (LVOT) gradients may be reproduced with dobutamine (DBT) provocation test in obstructive HCM patients under general anesthesia and to analyze the change in anatomic LVOT area and pressure gradients (PG) before and after septal myectomy. If the DBT stress test can reproduce preoperative gradients in HCM patients during septal myectomy surgery, surgeons will have the opportunity to assess the quality of the surgical procedure depending on the obtained gradients with DBT stress test after surgery when gradients can't be reproduced during general anesthesia after myectomy, and decide if further myectomy is required, saving a re-operation on the patient in the future.


Clinical Trial Description

Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy. Echocardiography is the noninvasive method of choice for the evaluation of morphologic and functional abnormalities in HCM. It is of paramount importance to distinguish between obstructive or non-obstructive HCM, based on the presence or absence of left ventricle outflow tract (LVOT) gradient using continuous wave Doppler (CWD), under resting and/or provocable conditions. HCM can then be divided into three different subgroups. When the gradient at rest is ≥ 30 mmHg the HCM is considered obstructive (HOCM); when the gradient is <30 mmHg at rest but ≥ 30 mmHg with provocation, the HCM is considered latent obstructive, and finally, non-obstructive occurs when the gradient is < 30mmHg at rest or with provocation. The gold standard technique to treat symptomatic HOCM is the surgical transaortic septal myectomy, when the resting gradient or the provocable gradient is ≥50 mmHg. Hemodynamic conditions may change and lead to worsening or improvement in LVOT obstruction during general anesthesia. LVOT gradients during surgery should be measured under reproducible conditions possibly mimicking preoperative hemodynamics. Dobutamine is a well-known inotropic agent, capable to induce sub-aortic gradients in HOCM. The development of a dynamic LVOT gradient during this test is a pharmacological phenomenon with no clinical significance, not been associated with increased frequency of chest pain, shortness of breath or ischemic wall motion abnormalities, because obstruction resolves after termination of dobutamine (DBT) infusion. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05025644
Study type Interventional
Source University Health Network, Toronto
Contact Jacobo Moreno Garijo, MD
Phone (416) 340-4800
Email [email protected]
Status Not yet recruiting
Phase Phase 4
Start date August 2021
Completion date August 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04905173 - Comparison of Squat-to-Stand Maneuver With Amyl Nitrite, Valsalva, and Exercise Stress Echocardiography in Inducing Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy N/A
Completed NCT04777188 - Speckle Tracking Echocardiography Analysis of Left Ventricular Myocardium After Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy N/A
Completed NCT02054221 - Surgical Treatment of Hypertrophic Obstructive Cardiomyopathy With Severe Mitral Insufficiency. N/A
Recruiting NCT04066777 - The Effect of TASH in Patients With HOCM N/A
Recruiting NCT02674958 - Mobilization of Endothelial Progenitor Cells and Aspirin Phase 3
Not yet recruiting NCT04329689 - Hyp Obst Cardiomyopathy N/A
Recruiting NCT04470102 - Edge-to-edge Mitral Valve Repair in the Surgical Treatment for Hypertrophic Cardiomyopathy N/A
Recruiting NCT04355260 - The Clinical Research of the Safety and Effectiveness Evaluation for Using Echocardiography-guided Liwen RF Radiofrequency Ablation System to Treat Hypertrophic Obstructive Cardiomyopathy N/A
Recruiting NCT02492399 - Comparisonof Extended Myoectomy and Myoectomy by Morrow in Patients With Hypertrophic Obstructive Cardiomyopathy (HOCM) N/A
Recruiting NCT04686487 - SterEotactic AbLative Radiotherapy in PatiEnts With HypertrophiC ObstrucTive Cardiomyopathy N/A
Not yet recruiting NCT04275544 - Risk Factors of Postoperative Complications in HCM Patients
Active, not recruiting NCT04141891 - Advancing Understanding of Transportation Options N/A
Completed NCT03877731 - Mitral Valve in Hypertrophic Cardiomyopathy N/A
Recruiting NCT04080492 - Inherited and Non-inherited Cardiac Disease Quality of Life
Recruiting NCT02888132 - Echocardiography-guided Transthoracic Radio Frequency/Laser Ablation for Ventricular Septum of Hypertrophic Obstructive Cardiomyopathy N/A
Recruiting NCT04770142 - First-in-Man Early Feasibility Study for Transcatheter HOCM Septal Ablation N/A